3-(1-Methyl-1H-indol-3-yl)propanenitrile, 1g

4,5-Dihydro-7-[3-(trifluoromethyl)phenyl]pyrazolo-[1,5-a]pyrimidine-3-carboxamide, 95.0%, 10g

3-Fluoro-2,4-dimethoxyaniline, 95.0%, 5g

1-(azetidin-3-yl)ethan-1-ol hydrochloride, 95.0%, 500mg

5-Hydroxyindole-3-acetic Acid>98.0%(HPLC)(T)100mg

(S)-4-Benzyl-2-((benzyloxy)methyl)-1,4-oxazepane, 98%, 1g

(1s,3r)-3-Amino-n,1-dimethyl-cyclopentanecarboxamidehydrochloride, 98%, 1g

(1R,3S,E)-5-((E)-2-((1R,3aS,7aR)-1-((2R,5S,E)-5-Cyclopropyl-5-hydroxypent-3-en-2-yl)-7a-methylhexahydro-1H-inden-4(2H)-ylidene)ethylidene)-4-methylenecyclohexane-1,3-diol, 98%, 1g

3-(Methylthio)propylamine, 98%, 1g

6-Methoxy-7-hydroxyquinazolin-4-one, 95.0%, 100g

Methyl 4-amino-6-chloronicotinate, 95.0%, 5g

Ethyl 5-bromo-1-methyl-1H-pyrazole-3-carboxylate, 95.0%, 25g

Dimethyl Suberate>98.0%(GC)500mL